Bruce Jancin
News
Presepsin can rule out invasive bacterial infection in infants
August 16, 2019
LJUBLJANA, SLOVENIA – Novel test addresses unmet need for biomarker for invasive bacterial infection.
News
‘Substantial burden’ of enterovirus meningitis in young infants
August 16, 2019
LJUBLJANA, SLOVENIA – “Not a single one of the patients with enterovirus/human parechovirus meningitis had a secondary bacterial infection – and that has important implications for management of our antibiotic stewardship programs,” said Dr. Seilesh Kadambari.
News
Novel score spots high-risk febrile children in ED
August 13, 2019
LJUBLJANA, SLOVENIA – The age-adapted pediatric quick Sequential Organ Failure Assessment score had a 99.6% negative predictive value.
News
Hospital slashes S. aureus vancomycin resistance
August 7, 2019
LJUBLJANA, SLOVENIA – Staphylococcus aureus resistance to vancomycin is not a one-way street ending in a cliff plunge.
News
Statins crush early seizure risk poststroke
July 18, 2019
BANGKOK – Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study.
News
What’s new in pediatric sepsis
June 26, 2019
LJUBLJANA, SLOVENIA – Don’t obsess about “Golden Hour” for delivering sepsis treatment bundle, expert advises.
News
Rapid assay distinguishes viral from bacterial infection
June 14, 2019
LJUBLJANA, SLOVENIA – Aim is to cut inappropriate antimicrobial therapy in febrile children while awaiting culture results.
News
Reducing pediatric RSV burden is top priority
June 11, 2019
LJUBLJANA, SLOVENIA – “RSV is by far the hottest virus in the world,” said Dr. Terho Heikkinen.
News
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
May 9, 2019
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.
News
PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan
April 14, 2019
NEW ORLEANS – “The early improvement in postdischarge outcomes supports the in-hospital initiation of sacubitril/valsartan.” – Dr. Adam D. DeVore